We identified CD49f to be highly expressed in OHBBN-induced bladder cancers and, thus, tested whether the CD49f-Epcam marker combination may provide a method to discern lineage heterogeneity within the same tumor as previously hypothesized6. The gene discussed is ITGA6; the disease is urinary bladder carcinoma.